Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization

Clinical and Experimental Metastasis

Volumn 29, Issue 5, 2012, Pages 397-408

  Bainer, Russell O ^a   Veneris, Jennifer Taylor ^a,b   Yamada, S Diane ^a   Montag, Anthony ^a   Lingen, Mark W ^a   Gilad, Yoav ^a   Rinker Schaeffer, Carrie W ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

MAP kinase kinase 4; Metastasis suppressor; Microarray timecourse; Omentum; Ovarian cancer; Transcriptional profiling

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MAP2K4 PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINESIS; CYTOSKELETON; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; OMENTAL METASTASIS; OVARY CARCINOMA; PERITONEUM METASTASIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN MICROARRAY; ANIMAL; COMPARATIVE STUDY; DNA MICROARRAY; DRUG SCREENING; ENZYME IMMUNOASSAY; ENZYMOLOGY; GENETICS; METABOLISM; METASTASIS; MOUSE; OMENTUM; OVARY TUMOR; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; MAP KINASE KINASE 4; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OMENTUM; OVARIAN NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELL ASSAY;

EID: 84862306938     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9448-y     Document Type: Article

References (38)

1. Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38(9):2651-2660 (Pubitemid 9001502)
2. Poste G, Fidler IJ (1980) The pathogenesis of cancer metastasis. Nature 283(5743):139-146 (Pubitemid 10171124)
3. Taylor JL et al (2008) New paradigms for the function of JNKK1/ MKK4 in controlling growth of disseminated cancer cells. Cancer Lett 272(1):12-22
4. Thiolloy S et al (2011) Thinking outside the box: using metastasis suppressors as molecular tools. Semin Cancer Biol 21(2):89-98
5. Cunningham SC et al (2006) MKK4 status predicts survival after resection of gastric adenocarcinoma. Arch Surg 141(11):1095-1099 discussion 1100 (Pubitemid 44790537)
6. Yamada SD et al (2002) Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res 62(22):6717-6723 (Pubitemid 35364143)
7. Yeasmin S et al (2011) MKK4 acts as a potential tumor suppressor in ovarian cancer. Tumour Biol 32(4):661-670
8. Kim HL et al (2001) Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res 61(7):2833-2837 (Pubitemid 32691920)
9. Szmulewitz RZ et al (2011) MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression. Int J Cancer. doi:10.1002/ijc.26005
10. Berchuck A et al (2004) Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. Am J Obstet Gynecol 190(4):910-925 (Pubitemid 38561506)
11. Hickson JA et al (2006) The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res 66(4):2264-2270
12. Lotan TL et al (2008) c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip. 1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Cancer Res 68(7): 2166-2175
13. Smyth GK, Speed T (2003) Normalization of cDNA microarray data. Methods 31(4):265-273 (Pubitemid 37338763)
14. Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98(1):31-36 (Pubitemid 32095858)
15. Gautier L et al (2004) affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20(3):307-315 (Pubitemid 38262761)
16. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100(16):9440-9445 (Pubitemid 37033947)
17. Dennis G Jr et al (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4(5):P3
18. Huang DW, Sherman B, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44-57
19. Hendrix ND et al (2006) Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res 66(3):1354-1362 (Pubitemid 43259914)
20. Riker AI et al (2008) The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 1:13
21. Pantaleo MA et al (2008) Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice. Br J Cancer 99(10):1729-1734
22. Scotlandi K et al (2009) Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome. J Clin Oncol 27(13):2209-2216
23. Dressman HK et al (2007) An integrated genomic-based approach to individualized treatment of patients with advancedstage ovarian cancer. J Clin Oncol 25(5):517-525 (Pubitemid 350002958)
24. Tothill RW et al (2008) Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 14(16):5198-5208
25. Shoushtari AN et al (2011) Metastasis-suppressor genes in clinical practice: lost in translation? Nat Rev Clin Oncol 8(6): 333-342
26. Lee JY et al (2011) Farnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion. Br J Cancer 104(6):1027-1037
27. Saito N et al (2009) Dynamics of global gene expression changes during brain metastasis formation. Neuropathology 29(4): 389-397
28. Dutertre M et al (2010) Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis. Cancer Res 70(3):896-905
29. van de Vijver MJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25): 1999-2009 (Pubitemid 35461656)
30. Ye QH et al (2003) Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9(4):416-423
31. Gupta PB et al (2005) The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet 37(10):1047-1054 (Pubitemid 41486656)
32. Matsuda Y et al (2009) WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res 11(3):R32
33. Minn AJ et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436(7050):518-524 (Pubitemid 41112921)
34. DeLisser H et al (2010) Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression. Proc Natl Acad Sci USA 107(43):18616-18621
35. McGilvray ID et al (2002) Monocyte adhesion and transmigration induce tissue factor expression: role of the mitogen-activated protein kinases. Shock 18(1):51-57
36. Wu SC et al (2008) Hepatitis C virus NS5A protein down-regulates the expression of spindle gene Aspm through PKR-p38 signaling pathway. J Biol Chem 283(43):29396-29404
37. Marasa BS et al (2009) Increased MKK4 abundance with replicative senescence is linked to the joint reduction of multiple microRNAs. Sci Signal 2(94):ra69
38. Yeasmin S et al (2011) Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transition. Int J Cancer 128(1):94-104